| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88205308 | FILING DATE | 11/26/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | FRIEDMAN, LESLEE ANN |
L.O. ASSIGNED | N20-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 09/12/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 09/11/2019 | ||
| LITERAL MARK ELEMENT | IPEC | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | IPEC |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Essenlix Corporation |
| ADDRESS | 1 Deerpark Drive, Suite R Monmouth Junction, NJ 08852 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Assays for research purposes; Biological and chemical reagents used for non-medical research purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample for laboratory or research use |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for the detection of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; medical diagnostic devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely, instruments for medical testing in the nature of the detection and identification of nucleic acids, namely, DNA and RNA in a sample |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of diagnostic testing, and wellness counseling services, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample for medical purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 09/11/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 017 |
| 09/11/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 016 |
| 09/11/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 015 |
| 09/11/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 014 |
| 09/11/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 013 |
| 09/11/2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 012 |
| 09/11/2019 | GNFR | O | FINAL REFUSAL E-MAILED | 011 |
| 09/11/2019 | CNFR | R | FINAL REFUSAL WRITTEN | 010 |
| 08/21/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 08/21/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 08/21/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 02/27/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 02/27/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 02/27/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 02/26/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 12/13/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 11/29/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Julian D. Gonzalez |
| CORRESPONDENCE ADDRESS | JULIAN D. GONZALEZ 1 DEERPARK DRIVE, SUITE R MONMOUTH JUNCTION, NJ 08852 |
| DOMESTIC REPRESENTATIVE | NONE |